XCELL® PRP System Benchtop Platelet-Rich Plasma Processing Station

Product Overview & Description The XCELL PRP® System is an advanced benchtop centrifugal processing platform designed for the rapid, precise, and high-yield preparation of autologous Platelet-Rich Plasma (PRP) from peripheral whole blood at the patient’s point of care. Engineered for maximum efficiency, the system utilizes a single 10-minute spin cycle to achieve up to an 8x baseline platelet concentration, yielding over 10 billion platelets per dose with an 84% capture rate. Featuring an intuitive hand-controlled dial and versatile processing options, the XCELL PRP system allows clinicians to produce both leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) formulations in customizable dosing volumes within a single platform. The resulting PRP can be combined with autograft and/or allograft bone matrices to enhance handling characteristics during orthopedic and surgical procedures. About This Item High Platelet Concentration: Consistently delivers up to an 8x concentration above baseline, yielding over 10 billion total platelets per dose with an 84% capture rate. Single 10-Minute Spin Cycle: Streamlines point-of-care workflow with an efficient, single-centrifugation process using the Drucker Boost 4+ Flex Centrifuge. Complete Buffy Coat Capture: Advanced benchtop station with a hand-controlled dial ensures precise separation and consistent capture of the entire buffy coat layer. Flexible Dual Formulation: Allows customization between leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) preparations within one system. All-In-One System Components: System includes the Drucker Boost 4+ Flex Centrifuge, benchtop processing station, digital scale, and sterile 60 mL single-use processing kits. Indications & Usage Primary Indication: Safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of peripheral blood at the patient’s point of care. Clinical Application: Intended for mixing with autograft and/or allograft bone prior to application to a bony defect to improve handling characteristics. Administration: Processed and applied at point of care by qualified healthcare professionals in clinical, surgical, or outpatient settings. Summary of Safety & Contraindications Contraindications: Contraindicated for use in non-sterile environments, in patients taking aspirin within 72 hours or drugs affecting platelet function, or in patients with serious medical conditions preventing safe tolerance of extracorporeal blood handling. Usage Restriction: Blood products processed with this device are for autologous point-of-care application only and must NOT be used for transfusion. Product Specifications Brand Name: XCELL PRP® Manufacturer: Apex Biologix / Bioventus LLC System Type: Point-of-Care Autologous Centrifugal PRP Processing Platform Spin Cycle: Single 10-minute spin Regulatory Notice: This product is strictly classed as a medical device (not a medicine).